Citation Impact
Citing Papers
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Circadian oscillation of nucleotide excision repair in mammalian brain
2009 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
The Comparative Effects of Postoperative Analgesic Therapies on Pulmonary Outcome
1998
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
2005
Nano hemostat solution: immediate hemostasis at the nanoscale
2006
Cholelithiasis following Escherichia coli O157?:?H7-associated hemolytic uremic syndrome
1998
EGFR Antagonists in Cancer Treatment
2008 Standout
Hepatocellular carcinoma
2003 Standout
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma
2003
Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy
1996
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors
2000
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective
2002
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
2004
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
2010
R1 Resection by Necessity for Colorectal Liver Metastases
2008
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Circadian variation of cell proliferation and cell cycle protein expression in man: Clinical implications
2000
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
2017
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
1996
The resurgence of platinum-based cancer chemotherapy
2007 Standout
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors
2003
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
Hepatocellular carcinoma
2012 Standout
Hepatobiliary surgery
2000
Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers
1995
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
2004 Standout
Oxaliplatin (L-OHP): a new reality in colorectal cancer
1998
Biliary Sludge as a Cause of Acute Pancreatitis
1992
Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein
2010 StandoutNobel
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Colorectal cancer prevention and treatment
2000
New Cisplatin Analogues in Development
1993
An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
2011
Colorectal cancer
2019 Standout
Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients
2003
Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
2008
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Right Portal Vein Ligation: A New Planned Two-Step All-Surgical Approach for Complete Resection of Primary Gastrointestinal Tumors with Multiple Bilateral Liver Metastases
2003
Peritoneal Surface Disease from Colorectal Cancer: Comparison with the Hepatic Metastases Surgical Paradigm in Optimally Resected Patients
2008
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
2007
Circadian rhythms and cancer chemotherapy
1995
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
1996
Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases: Perioperative Safety and Survival
2007
A Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery
2013 Standout
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer
1999
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis
1997
In Vivo Destruction of Tumor Tissue by Cryoablation Can Induce Inhibition of Secondary Tumor Growth: An Experimental Study
2001
Acute Pancreatitis
1994 Standout
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
1998
Safety and Efficacy of Radiofrequency Thermal Ablation in Advanced Liver Tumors
2001
Epidural Anesthesia and Analgesia
1995
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial
2002 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies #
2008
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
2019
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Pharmacological Modulation of Cisplatin Toxicity Rhythms with Buthionine Sulfoximine in Mice Bearing Pancreatic Adenocarcinoma (PO3)
1998
New platinum antitumor complexes
1993
Hepatocellular Carcinoma
2011 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
New Developments and Approaches in the Platinum Arena
2000
Oxaliplatin in practice
1998
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
The role of DNA mismatch repair in platinum drug resistance.
1996
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer
2007
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Hepatocellular Carcinoma
1988
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Circadian Rhythms: Mechanisms and Therapeutic Implications
2007
Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals
2022 StandoutScienceNobel
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
The Comparative Effects of Postoperative Analgesic Therapies on Pulmonary Outcome
1998
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Coupling of Human Circadian and Cell Cycles by the Timeless Protein
2005 StandoutNobel
Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
2018
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
The Role of Clock Genes in Pharmacology
2010
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
2003
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
2007
Formation of Glyco-Functionalized Platinum Complexes by Cross-Metathesis and Evaluation of Their Efficacy in Inhibition of Lung Tumor Cell Lines
2012
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases
2020
Postoperative Noninvasive Ventilation
2010
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
2003
Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen
1999
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
1999
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
1997
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of F Kunstlinger being referenced
Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperative pain.
1983
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
1999
A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
1992
Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy
2004
Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer.
1996
Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial
1994
Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases
2001
Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
2015
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
1993
Place of Cryosurgery in the Treatment of Malignant Liver Tumors
1997
Vascular occlusive agents
1981
Surgery Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperativepain
1985
The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
2012
OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer
2005
Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?
1983
Computed tomography of hepatocellular carcinoma
1980